Skip to main content

Table 1 Demography and laboratory parameters

From: Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients

Age, years 71 (61–77)
Female/male, n 11/33
Dialysis vintage, months 36 (20–72)
Body mass index, kg/m2 25.0 (23.0–29.5)
Diabetes mellitus, n 23
Cardiovascular disease, n 30
Primary kidney disease, n
Diabetes mellitus 12
Chronic glomerulonephritis 5
Nephrosclerosis 7
Polycystic kidney disease 4
Vasculitis 2
Other or unknown disease 14
Medications, n
Beta-blockers 25
ACEi/ARBs 9
Statins 15
  1. Data presented as number of patients (n), or as median and interquartile range (IQR). Abbreviations: ACEi angiotensin converting enzyme inhibitor, ARBs angiotensin receptor blockers